Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun;44(2):107-12.
doi: 10.2478/v10019-010-0028-6. Epub 2010 May 24.

Antigen expression on recurrent meningioma cells

Andrej Vranic  1
Affiliations

Antigen expression on recurrent meningioma cells

Andrej Vranic. Radiol Oncol. 2010 Jun.

Abstract

Introduction: Meningiomas are intracranial brain tumours that frequently recur. Recurrence rates up to 20% in 20 years for benign meningiomas, up to 80% for atypical meningiomas and up to 100% for malignant meningiomas, have been reported. The most important prognostic factors for meningioma recurrence are meningioma grade, meningioma invasiveness and radicality of neurosurgical resection. The aim of our study was to evaluate the differences in antigenic expression on the surface of meningioma cells between recurrent and non-recurrent meningiomas.

Methods: 19 recurrent meningiomas and 35 non-recurrent meningiomas were compared regarding the expression of MIB-1 antigen, progesterone receptors, cathepsin B and cathepsin L, using immunohistochemistry.

Results: MIB-1 antigen expression was higher in the recurrent meningioma group (p=0.001). No difference in progesterone receptor status between recurrent and non-recurrent meningiomas was confirmed. Immunohistochemical intensity scores for cathepsin B (p= 0.007) and cathepsin L (p<0.001) were both higher in the recurrent than in the non-recurrent meningioma group.

Conclusions: [corrected] MIB-1 antigen expression is higher in recurrent compared to non-recurrent meningiomas. There is no difference in expression of progesterone receptors between recurrent and non-recurrent meningiomas. Cathepsins B and L are expressed more in recurrent meningiomas.

Keywords: cathepsin B; cathepsin L; meningioma; proliferation index, MIB-1 antigen; recurrence; tumour markers.

PubMed Disclaimer

Figures

FIGURE 1
FIGURE 1
Expression of MIB-1 antigen in different meningioma grades comparing non-recurrent and recurrent meningiomas.
FIGURE 2
FIGURE 2
Expression of PR in different meningioma grades comparing non-recurrent and recurrent meningiomas.
FIGURE 3
FIGURE 3
IH intensity score of cathepsin B expression in different meningioma grades comparing non-recurrent and recurrent meningiomas.
FIGURE 4
FIGURE 4
IH intensity score of cathepsin L expression in different meningioma grades comparing non-recurrent and recurrent meningiomas.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ayerbe J, Lobato RD, Cruz J, Cabrera A. Risk factors predicting recurrence in patients operated on for intracranial meningioma. A multivariate analysis. Acta Neurochir. 1999;141:921–32. - PubMed
    1. Black P. 643 meningiomas: current perspective. Neurosurgery. 2003;32:643–57. - PubMed
    1. De Monte F, Marmor E, Al-Mefty O. Meningiomas. In: Kaye AH, editor. Brain tumours. London: Harcourt Publishers; 2001. pp. 719–50.
    1. Jäaskelainen J. Seemingly complete removal of histologically benign intracranial meningioma: late recurrence rate and factors predicting recurrence in 657 patients. A mutivariate analysis. Surg Neurol. 1986;26:461–9. - PubMed
    1. Franko A, Holjar-Erlic I, Miletic D. Lateral ventricle epidermoid. Radiol Oncol. 2008;42:66–8.